kSIST-TS FprCEN ISO/TS 7552-1:2024
(Main)Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood - Part 1: Isolated RNA (ISO/DTS 7552-1:2024)
Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood - Part 1: Isolated RNA (ISO/DTS 7552-1:2024)
This document gives guidelines on the handling, storage, processing and documentation of human venous whole blood specimens intended for the examination of RNA isolated from circulating tumour cells (CTCs) during the pre-examination phase before a molecular examination is performed.
This document is applicable to molecular in vitro diagnostic examinations performed and/or developed by medical laboratories, in vitro diagnostics developers and manufacturers, institutions and commercial organizations performing biomedical research.
It is also intended to be used by laboratory customers including health institutions requesting examinations for their patients as well as biobanks and regulatory authorities.
This document does not cover the isolation of cellular RNA directly from venous whole blood containing CTCs. This is covered in ISO 20186-1, Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood – Part 1: Isolated cellular RNA.
This document does not cover the isolation of specific white blood cells and subsequent isolation of cellular RNA therefrom.
This document does not cover pre-analytical workflow requirements for viable CTC cryopreservation and culturing.
NOTE 1 The requirements given in this document can also be applied to other circulating rare cells (e.g. fetal cells).
NOTE 2 International, national or regional regulations or requirements can also apply to specific topics covered in this document.
Spezifikationen für präanalytische Prozesse für zirkulierende Tumorzellen (CTC) in venösen Vollblutproben - Teil 1: Isolierte RNA (ISO/DTS 7552-1:2024)
Dieses Dokument legt Anforderungen fest und gibt Empfehlungen zur Handhabung, Lagerung, CTC Anreicherung und Isolierung, RNA Isolierung und Lagerung sowie Dokumentation von venösem Vollblut-Untersuchungsmaterial, das für die Untersuchung der aus zirkulierenden Tumorzellen (CTC) isolierten RNA vorgesehen ist, während der präanalytischen Phase vor der Durchführung einer molekularen Analyse.
Dieses Dokument ist anwendbar auf molekulare in vitro-diagnostische Untersuchungen, die in medizinischen Laboratorien durchgeführt werden, einschließlich vom Laboratorium selbst entwickelter Verfahren. Es ist darüber hinaus für die Verwendung durch Kunden von Laboratorien, Entwickler und Hersteller von In vitro-Diagnostika, durch Biobanken, Institutionen und kommerzielle Organisationen, die biomedizinische Forschung betreiben, sowie durch Arzneimittelagenturen bestimmt.
Dieses Dokument behandelt nicht die direkte Isolierung von zellulärer RNA aus venösen Vollblutproben, die CTC enthalten. Diese wird in ISO 20186 1 behandelt.
Dieses Dokument behandelt nicht die Isolierung von bestimmten weißen Blutzellen (Leukozyten) und die anschließende Isolierung von zellulärer RNA aus diesen Zellen. Dieses Dokument behandelt auch nicht die Anforderungen an den präanalytischen Arbeitsablauf zur Kryokonservierung und Kultivierung lebensfähiger CTC.
ANMERKUNG 1 Die in diesem Dokument dargelegten Anforderungen können auch auf andere zirkulierende Zellen (z. B. fetale Zellen) angewendet werden.
ANMERKUNG 2 Internationale, nationale oder regionale Regelungen bzw. Anforderungen können ebenfalls für bestimmte Themen in diesem Dokument gelten.
Titre manque - Partie 1: Titre manque (ISO/DTS 7552-1:2024)
Molekularne diagnostične preiskave in vitro - Specifikacije za predpreiskovalne procese za cirkulirajoče tumorske celice (CTC) v venski polni krvi - 1. del: Izolirana RNK (ISO/DTS 7552-1:2024)
General Information
Relations
Standards Content (Sample)
SLOVENSKI STANDARD
01-september-2024
Nadomešča:
SIST-TS CEN/TS 17390-1:2020
Molekularne diagnostične preiskave in vitro - Specifikacije za predpreiskovalne
procese za cirkulirajoče tumorske celice (CTC) v venski polni krvi - 1. del: Izolirana
RNK (ISO/DTS 7552-1:2024)
Molecular in vitro diagnostic examinations - Specifications for pre-examination processes
for circulating tumour cells (CTCs) in venous whole blood - Part 1: Isolated RNA
(ISO/DTS 7552-1:2024)
Spezifikationen für präanalytische Prozesse für zirkulierende Tumorzellen (CTC) in
venösen Vollblutproben - Teil 1: Isolierte RNA (ISO/DTS 7552-1:2024)
Titre manque - Partie 1: Titre manque (ISO/DTS 7552-1:2024)
Ta slovenski standard je istoveten z: FprCEN ISO/TS 7552-1
ICS:
11.100.10 Diagnostični preskusni In vitro diagnostic test
sistemi in vitro systems
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.
FINAL DRAFT
Technical
Specification
ISO/DTS 7552-1
ISO/TC 212
Molecular in vitro diagnostic
Secretariat: ANSI
examinations — Specifications
Voting begins on:
for pre-examination processes for
2024-07-15
circulating tumour cells (CTCs) in
Voting terminates on:
venous whole blood —
2024-10-07
Part 1:
Isolated RNA
RECIPIENTS OF THIS DRAFT ARE INVITED TO SUBMIT,
WITH THEIR COMMENTS, NOTIFICATION OF ANY
RELEVANT PATENT RIGHTS OF WHICH THEY ARE AWARE
AND TO PROVIDE SUPPOR TING DOCUMENTATION.
IN ADDITION TO THEIR EVALUATION AS
BEING ACCEPTABLE FOR INDUSTRIAL, TECHNO-
ISO/CEN PARALLEL PROCESSING LOGICAL, COMMERCIAL AND USER PURPOSES, DRAFT
INTERNATIONAL STANDARDS MAY ON OCCASION HAVE
TO BE CONSIDERED IN THE LIGHT OF THEIR POTENTIAL
TO BECOME STAN DARDS TO WHICH REFERENCE MAY BE
MADE IN NATIONAL REGULATIONS.
Reference number
ISO/DTS 7552-1:2024(en) © ISO 2024
FINAL DRAFT
ISO/DTS 7552-1:2024(en)
Technical
Specification
ISO/DTS 7552-1
ISO/TC 212
Molecular in vitro diagnostic
Secretariat: ANSI
examinations — Specifications
Voting begins on:
for pre-examination processes for
circulating tumour cells (CTCs) in
Voting terminates on:
venous whole blood —
Part 1:
Isolated RNA
RECIPIENTS OF THIS DRAFT ARE INVITED TO SUBMIT,
WITH THEIR COMMENTS, NOTIFICATION OF ANY
RELEVANT PATENT RIGHTS OF WHICH THEY ARE AWARE
AND TO PROVIDE SUPPOR TING DOCUMENTATION.
© ISO 2024
IN ADDITION TO THEIR EVALUATION AS
All rights reserved. Unless otherwise specified, or required in the context of its implementation, no part of this publication may
BEING ACCEPTABLE FOR INDUSTRIAL, TECHNO-
ISO/CEN PARALLEL PROCESSING
LOGICAL, COMMERCIAL AND USER PURPOSES, DRAFT
be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying, or posting on
INTERNATIONAL STANDARDS MAY ON OCCASION HAVE
the internet or an intranet, without prior written permission. Permission can be requested from either ISO at the address below
TO BE CONSIDERED IN THE LIGHT OF THEIR POTENTIAL
or ISO’s member body in the country of the requester.
TO BECOME STAN DARDS TO WHICH REFERENCE MAY BE
MADE IN NATIONAL REGULATIONS.
ISO copyright office
CP 401 • Ch. de Blandonnet 8
CH-1214 Vernier, Geneva
Phone: +41 22 749 01 11
Email: copyright@iso.org
Website: www.iso.org
Published in Switzerland Reference number
ISO/DTS 7552-1:2024(en) © ISO 2024
ii
ISO/DTS 7552-1:2024(en)
Contents Page
Foreword .iv
Introduction .v
1 Scope . 1
2 Normative references . 1
3 Terms and definitions . 1
4 General considerations . 5
5 Activities outside the laboratory. 6
5.1 Specimen collection .6
5.1.1 General .6
5.1.2 Information about the specimen donor/patient.6
5.1.3 Selection of the venous whole blood collection tube by the laboratory .7
5.1.4 Venous whole blood specimen collection from the patient/donor .7
5.2 Specimen storage and transport .8
5.2.1 General .8
5.2.2 Storage and transport using blood collection tubes with stabilizers .8
5.2.3 Storage and transport using blood collection tubes without stabilizers .9
6 Activities inside the laboratory . 9
6.1 Specimen reception .9
6.2 Specimen storage after transport and reception .9
6.3 Enrichment of CTCs .9
6.3.1 General .9
6.3.2 Using a commercial CTC enrichment system intended for diagnostic use .10
6.3.3 Using the laboratory-developed CTC enrichment procedure.10
6.4 Quality of enriched CTCs .11
6.5 Storage of enriched CTCs .11
6.6 Isolation of CTCs .11
6.6.1 General .11
6.6.2 Using a commercial CTC isolation system intended for diagnostic use . 12
6.6.3 Using the laboratory-developed CTC isolation procedure . 12
6.7 Isolation of RNA from an enriched CTC sample . 12
6.7.1 General . 12
6.7.2 Using a commercial RNA isolation kit intended for diagnostic use . 12
6.7.3 Using a laboratory-developed CTC RNA isolation procedure . 13
6.8 Quantity and quality assessment of isolated RNA from enriched or isolated CTCs . 13
6.8.1 General . 13
6.8.2 Quantity assessment of CTC RNA . 13
6.8.3 Quality assessment CTC RNA .14
6.9 Storage of isolated RNA from enriched CTCs .14
6.9.1 General .14
6.9.2 Storage of RNA isolated with a commercially available kit intended for
diagnostic use . 15
6.9.3 Storage of RNA isolated with the laboratory-developed procedure . 15
Annex A (informative) Decision guideline for critical steps of the CTC pre-examination
workflow . 16
Bibliography .18
iii
ISO/DTS 7552-1:2024(en)
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out through
ISO technical committees. Each member body interested in a subject for which a technical committee
has been established has the right to be represented on that committee. International organizations,
governmental and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely
with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
The procedures used to develop this document and those intended for its further maintenance are described
in the ISO/IEC Directives, Part 1. In particular, the different approval criteria needed for the different types
of ISO documents should be noted. This document was drafted in accordance with the editorial rules of the
ISO/IEC Directives, Part 2 (see www.iso.org/directives).
ISO draws attention to the possibility that the implementation of this document may involve the use of (a)
patent(s). ISO takes no position concerning the evidence, validity or applicability of any claimed patent
rights in respect thereof. As of the date of publication of this document, ISO had not received notice of (a)
patent(s) which may be required to implement this document. However, implementers are cautioned that
this may not represent the latest information, which may be obtained from the patent database available at
www.iso.org/patents. ISO shall not be held responsible for identifying any or all such patent rights.
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
For an explanation of the voluntary nature of standards, the meaning of ISO specific terms and expressions
related to conformity assessment, as well as information about ISO's adherence to the World Trade
Organization (WTO) principles in the Technical Barriers to Trade (TBT), see www.iso.org/iso/foreword.html.
This document was prepared by Technical Committee ISO/TC 212, Clinical laboratory testing and in vitro
diagnostic test systems, in collaboration with the European Committee for Standardization (CEN) Technical
Committee CEN/TC 140, In vitro diagnostic medical devices, in accordance with the Agreement on technical
cooperation between ISO and CEN (Vienna Agreement).
A list of all parts in the ISO 7552 series can be found on the ISO website.
Any feedback or questions on this document should be directed to the user’s national standards body. A
complete listing of these bodies can be found at www.iso.org/members.html.
iv
ISO/DTS 7552-1:2024(en)
Introduction
Solid tumours release cells
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.